Vaccines and Public Health
Adult immunization rates are falling short of national targets. Learn how global, federal, and state policies affect vaccination uptake. Leverage our findings to guide your strategies. Rely on our expertise commercializing novel and therapeutic vaccines.
Several Changes to Adult Vaccine Access Enacted Through IRA
The IRA will expand adult vaccine access by mandating coverage without cost sharing for all adult vaccines in Medicare Part D and Medicaid.
Vaccine Incentives for Providers Would Change Due to 2 MPFS Proposals
CMS is proposing to update vaccine administration reimbursement rates annually and make changes to adult vaccination quality metrics, beginning in 2023.
Comparing Medicare FFS Pneumococcal Vaccination Rates in 2019 and 2020
A new study from Avalere analyzes age, race and ethnicity, and Medicare-Medicaid dual-eligibility status of Medicare Fee-For-Service (FFS) beneficiaries with pneumococcal vaccine claims in 2019 and 2020.
Addressing Climate Change Impacts on Health
As climate change continues to alter the patterns of everyday life, healthcare stakeholders should consider strategies to prevent and mitigate negative environmental contributions and proactively address the impacts of climate change on health outcomes, health equity, and healthcare costs.
Microarray Patches Could Improve Pandemic Vaccination
The rollout of COVID-19 vaccines highlights the need for continued innovation in how vaccines are delivered.
Midlife Prevention of Alzheimer’s Disease
Although Alzheimer’s disease has no known cure, recent evidence points to several advancements that may enhance the understanding of the progression of the disease.
Declines in Routine Adult and Teen Vaccinations Continued in 2021
Updated Avalere analysis shows that routine immunization continued to lag in 2021 below pre-pandemic levels, highlighting the continuing effect of COVID-19 on routine vaccination.
Avalere Research Highlights Alternative Settings for Vaccination
The CDC recommends HBV vaccinations for persons with a history of current or recent injection drug use, but uptake remains low. Avalere research shows an opportunity to leverage alternative care settings to address the growing rates of HBV infection.
Impact of Removing Part D Vaccine Cost-Sharing on the Federal Budget
The COVID-19 pandemic has brought renewed attention and urgency to mitigating access barriers to recommended vaccines.
Webinar: Driving Vaccine Access and Uptake
Join us for a live conversation exploring actionable strategies for driving greater vaccine access and adoption.
Vaccination Rates Among Medicaid Adolescents Declined During Pandemic
A new claims-based analysis from Avalere examined vaccine uptake among low-income adolescents enrolled in Medicaid Managed Care and found a 26% decline in routine vaccinations when comparing March–October 2019 to the same period in 2020.
Considerations for a Shift from Pandemic to Endemic COVID-19 Landscape
Stakeholders in the COVID-19 pandemic response face regulatory and commercial uncertainties as emergency operations transition and market access of products face both emergency use and full licensure.
Self-Administered Vaccines Present Broad Opportunities
The COVID-19 pandemic response has increased investment in vaccine innovations, but also exposed gaps in US and global vaccine access and delivery.
Webinar: Post-Pandemic Planning for Life Sciences Companies
Avalere’s data analytics and market access experts will be joined by Jeff Patton, MD and CEO of OneOncology, to explore critical issues and considerations for life sciences stakeholders following the pandemic.
Updated Analysis Finds Sustained Drop in Routine Vaccines Through 2020
In 2020, the COVID-19 pandemic resulted in nationwide lockdowns and restrictions with a well-documented impact on utilization of routine healthcare services.
Accurate COVID-19 Testing to Protect the Military and Support Schools
The US continues to face challenges with managing COVID-19 (SARS-CoV-2) while reopening communities. Accurate COVID-19 diagnostic testing is an effective tool in minimizing the risk of transmission.
Avalere Statement on US Support of TRIPS Waiver for COVID Vaccines
On May 5, the Biden administration announced its support for waiving World Trade Organization (WTO) intellectual property regulations with respect to COVID-19 vaccines, in an effort to increase supply and worldwide access to the vaccines.
Jason Hall and Tom Hess Bring Additional Vaccine Expertise to Avalere
They bring more than 35 years of combined healthcare experience and expertise in the immunization development sector.
The Need for a Centralized Immunization Information System
Immunization Information Systems (IIS), or immunization registries, are used across the US to provide consolidated and complete accounts of patient immunization history in a given city, state, or region.
Webinar: Equity for Seniors: Using Data to Guide COVID-19 Pandemic Recovery
Join leading experts from Avalere Health and Tivity Health to learn more about new analyses detailing seniors’ lived experiences with the COVID-19 pandemic, including recent survey data on the vaccine rollout nationwide.